Welcome to our dedicated page for Buda Juice SEC filings (Ticker: BUDA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Buda Juice, Inc. filings document the beverage company's transition to a NYSE American public issuer, including registration-statement prospectus materials, 8-K reports, underwriting agreements and common-stock issuance details from its initial public offering.
The company's regulatory disclosures also cover capital-structure items such as underwriter warrants, over-allotment option exercise, equity incentive plan adoption, shareholder voting matters and governance disclosures tied to its Ultra Fresh™ juice, lemonade and wellness-shot business.
Buda Juice reported strong revenue growth in its first full quarter as a public company but lower profits. For the quarter ended March 31, 2026, revenue rose 17.7% to $3.5 million from $3.0 million, while gross profit edged up to $1.4 million.
Higher selling, general and administrative expenses drove operating income down to $0.6 million from $0.8 million, and net income fell to $0.4 million from $0.8 million, or diluted EPS of $0.03. Non-GAAP net income was $0.6 million, with non-GAAP EPS of $0.05 and Adjusted EBITDA of $0.8 million.
Free cash flow reached $1.1 million, up 37% year over year. Cash on the balance sheet climbed to $19.8 million, largely reflecting $23.0 million of IPO proceeds, net of offering costs and a $3.75 million common stock redemption. The company also highlighted a post-quarter expansion of its Buda Fresh Cherry Limeade into 246 Walmart stores across nine states.
Buda Juice, Inc. reported higher sales but lower profit for the three months ended March 31, 2026, its first quarter as a public C‑corporation. Net sales rose to $3.5 million from $3.0 million a year earlier, driven mainly by increased demand from its primary grocery customer.
Gross profit inched up to $1.4 million, but gross margin fell to 39.5% from 44.9%, largely because lime prices spiked after supply disruptions in western Mexico. Operating expenses climbed to $0.8 million, mainly from higher personnel, insurance, and professional fees tied to the January 2026 IPO.
Net income declined to $0.4 million from $0.8 million, with the drop also reflecting a much higher income tax expense after converting from an LLC to a C‑corporation. The IPO and over‑allotment generated $16.9 million in net proceeds, boosting cash to $19.8 million and working capital to $19.9 million as of March 31, 2026, while the company kept its $3.0 million credit facility undrawn. One customer accounted for about 96% of quarterly revenue, underscoring significant customer concentration risk.
BUDA JUICE, INC. reports that Bernard Lucien Nussbaumer beneficially owns 2,904,860 shares of Common Stock, representing 20.64% of the class. The filing lists sole voting and dispositive power over 2,904,860 shares. The reporting person is identified as a Director and signed the filing on 04/02/2026.
BUDA JUICE, INC. reports that Director and Executive Chairman Bryan Herr beneficially owns 2,644,466 shares of Common Stock, representing 18.79% of the class. The filing lists 2,644,466 shares of sole voting and sole dispositive power. The form is signed 04/02/2026.
BUDA JUICE, INC. Schedule 13G reports that Horatio Lonsdale-Hands beneficially owns 2,249,417 shares of Common Stock, representing 15.98% of the class. The filing lists sole voting and dispositive power over the same 2,249,417 shares and includes CUSIP 11882T106.
Buda Juice, Inc. files its annual report for the year ended December 31, 2025, outlining a profitable but highly concentrated fresh-juice business. The company pioneers UltraFresh™ cold-crafted citrus juices and wellness shots, using a strict 35°F end-to-end cold chain and an asset-light logistics model serving grocery retailers in Texas.
Buda plans a three-hub expansion, adding projected facilities in South Carolina and Arizona/Nevada to reach more U.S. consumers. For 2025 and 2024, it reports net profit of $3.53 million and $3.57 million, respectively, with 39 full-time employees as of December 31, 2025.
Risk disclosures highlight reliance on one customer for 97% of 2025 net sales, exposure to fresh citrus supply and climate, short shelf-life and cold-chain complexity, food safety and regulatory compliance, inflationary logistics costs, and the added burden of public-company governance. Common stock trades on NYSE American under the symbol BUDA, with 12,566,666 shares outstanding as of March 26, 2026.
GROW Funds LLC filed an amendment on a Schedule 13G/A reporting beneficial ownership of 1,255,547 shares of Common Stock of BUDA JUICE, INC., representing 8.97% of the class. The filing is signed by Carl Wiese as CEO on 03/04/2026.
BUDA JUICE, INC. director Robert D. Burris reported his ownership of company stock in a Form 3. He directly holds 298,861 shares of common stock. This amount includes 198,703 shares of restricted common stock granted under the company’s 2025 Equity Incentive Plan. The filing does not report any new stock purchases or sales, but instead establishes his existing ownership position as an insider.
Buda Juice, Inc. director Hayat Mohammad reported ownership of 87,967 shares of restricted common stock. According to the footnote, these shares were granted under the company’s 2025 Equity Incentive Plan and are held directly by the reporting person.
BUDA JUICE, INC. director Marie Quintana filed an initial ownership report on Form 3, disclosing her holdings of the company’s common stock. She reports direct ownership of 110,122 shares of common stock. According to the footnote, this total includes 76,789 shares of restricted common stock granted under the 2025 Equity Incentive Plan.